{"address1": "Building 4", "address2": "Suite 200 3000 El Camino Real", "city": "Palo Alto", "state": "CA", "zip": "94306", "country": "United States", "phone": "650 507 0669", "website": "https://180lifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Sir Marc  Feldman Ph.D.", "age": 79, "title": "Co-Founder", "yearBorn": 1945, "fiscalYear": 2023, "totalPay": 232970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder & Director", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 168750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lloyd Blair Jordan L.L.B., M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Jagdeep  Nanchahal M.D., Ph.D.", "title": "Co-Founder & Chairman of Clinical Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric R. Van Lent", "title": "CAO, Principal Accounting & Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9801, "open": 0.99, "dayLow": 0.9, "dayHigh": 0.99, "regularMarketPreviousClose": 0.9801, "regularMarketOpen": 0.99, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 0.99, "payoutRatio": 0.0, "beta": 0.215, "trailingPE": 0.11904762, "forwardPE": -2.0652173, "volume": 40910, "regularMarketVolume": 40910, "averageVolume": 113673, "averageVolume10days": 27660, "averageDailyVolume10Day": 27660, "bid": 0.7, "ask": 1.22, "bidSize": 1, "askSize": 2, "marketCap": 3018150, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 17.75, "fiftyDayAverage": 1.2505, "twoHundredDayAverage": 1.95393, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2226453, "profitMargins": 0.0, "floatShares": 1400407, "sharesOutstanding": 3177000, "sharesShort": 55991, "sharesShortPriorMonth": 25915, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0176, "heldPercentInsiders": 0.18135999, "heldPercentInstitutions": 0.21320999, "shortRatio": 0.72, "shortPercentOfFloat": 0.0176, "impliedSharesOutstanding": 3177000, "bookValue": 3.636, "priceToBook": 0.26127613, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -3121788, "trailingEps": 7.98, "forwardEps": -0.46, "lastSplitFactor": "1:19", "lastSplitDate": 1709078400, "enterpriseToEbitda": -0.354, "52WeekChange": -0.579646, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.95, "recommendationKey": "none", "totalCash": 194920, "totalCashPerShare": 0.099, "ebitda": -6286719, "totalDebt": 483717, "quickRatio": 0.037, "currentRatio": 0.192, "debtToEquity": 12.955, "returnOnAssets": -0.51617, "returnOnEquity": -1.74185, "freeCashflow": -2010399, "operatingCashflow": -2689920, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ATNF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1743537600, "marketState": "PRE", "regularMarketChangePercent": -3.071114, "regularMarketPrice": 0.95, "shortName": "180 Life Sciences Corp.", "longName": "180 Life Sciences Corp.", "exchange": "NCM", "messageBoardId": "finmb_587644367", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketChange": -0.030099988, "regularMarketDayRange": "0.9 - 0.99", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 113673, "fiftyTwoWeekLowChange": 0.050000012, "fiftyTwoWeekLowChangePercent": 0.05555557, "fiftyTwoWeekRange": "0.9 - 17.75", "fiftyTwoWeekHighChange": -16.8, "fiftyTwoWeekHighChangePercent": -0.94647884, "fiftyTwoWeekChangePercent": -57.9646, "earningsTimestamp": 1743451200, "earningsTimestampStart": 1747166400, "earningsTimestampEnd": 1747684800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7.98, "epsForward": -0.46, "fiftyDayAverageChange": -0.30049998, "fiftyDayAverageChangePercent": -0.24030386, "twoHundredDayAverageChange": -1.0039301, "twoHundredDayAverageChangePercent": -0.51380044, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1498570200000, "displayName": "180 Life Sciences", "trailingPegRatio": null}